With more than 10 years of experience in the automotive industry, managing global projects and leading a global project management team, Tobias Porth has a rich background in handling complex, international initiatives. For the past year, he has brought his expertise to Boehringer Ingelheim's Animal Health business unit, where he serves as an Engineering Network Manager, playing a key role in Global Capex Management.

Katrin Farwig is Senior Director Technical Service Manufacturing Science (TSMS) at Elanco. She looks back on over 20 years of Pharma industry experience in the area of technical Project Management, Operations, and Supply Chain. During this time, she has been in different functions within Supply Chain / Operations, from a local site operations role to global project management and third-party management roles.

Stefan Kaupp is Director Quality Unit at BIPSO GmbH (Bracco Group). He is responsible for Quality Assurance at the plant of BIPSO GmbH in Singen. He has founded knowledge in Quality Assurance, GMP and transformation processes. Stefan Kaupp holds a PhD in Pharmacy.

Brian DiVasta is Director for Computer System Validation for elevatebio for 3+ years. There his specialities are computer validation and quality assurance. Before his position at elevatebio he was with Sanofi for 8+ years as Associate Director, ITS Compliance.

Holli Mayer is the Customer Training Manager at Cytiva, responsible for leading customer training initiatives across the U.S. and Canada. With over a decade of experience in bioprocessing, she specializes in downstream large-scale purification equipment, including single-use and chromatography column technologies. Her role encompasses designing and implementing training programs that equip customers with essential skills for equipment maintenance and troubleshooting. Holli has also held various technical and managerial positions at Cytiva and GE Healthcare, where she gained extensive expertise in field service, bioprocess hardware, and large-scale protein purification.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Elanco is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole.

Die BIPSO (Bracco Imaging Pharmaceutical Sterile Operations) GmbH wurde 2011 durch einen Betriebsübergang gegründet und ist der wichtigste Produktionsstandort für sterile Kontrastmittel der Bracco Group. Trotz seiner relativ jungen Jahre, steckt jede Menge Erfahrung in der Unternehmens-DNA der BIPSO GmbH. Der Grundstein des Bracco-Konzerns wurde bereits 1927 von der italienischen Familie Bracco gelegt, die das Unternehmen bis heute bereits in der vierten Generation leitet.

ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built state-of-the-art facilities, and integrated diverse technology platforms, including gene editing, induced pluripotent stem cells (iPSCs), and protein, vector, and cellular engineering, necessary to drive innovation and commercialization of cellular and genetic medicines. In addition, ElevateBio BaseCamp is a purpose-built, technology-enabled manufacturing platform offering process innovation, process sciences, and current Good Manufacturing Practice (cGMP) manufacturing capabilities for viral vectors, RNA, and cell therapy production. Through BaseCamp, its expanding footprint, and its next-generation enabling technologies, ElevateBio is rapidly growing its collaborations with industry partners while also selectively developing its own portfolio of cellular and genetic medicines. ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.

At Cytiva, we envision a world in which access to life-changing therapies transforms human health. With a rich heritage dating back hundreds of years, our wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. Cytiva is part of Danaher, a global science and technology leader. Along with Danaher’s diagnostic and life sciences businesses, we bring an innovative mindset to our collaborations with customers to help them improve patient outcomes.